logo
Biden's prostate cancer diagnosis raises questions about screening and how the disease spreads

Biden's prostate cancer diagnosis raises questions about screening and how the disease spreads

CBS News19-05-2025

Former President Joe Biden's diagnosis with an advanced stage of prostate cancer that has metastasized, or spread, to his bones prompted an outpouring of concern and questions about his condition. Those questions include how long the cancer may have taken to develop and whether he was screened for it during earlier checkups.
While it's unclear exactly how long Biden has had cancer, its rapid spread is attributed to it being an aggressive form of the disease. His cancer was categorized as having a Gleason score of 9, which places him in Grade Group 5, the most severe category. The Gleason score is a system for grading the severity of prostate cancer based on analysis of cell samples under a microscope.
When prostate cancer is more advanced and spreads, the bones are among the areas most likely to be affected. It can also commonly spread to the lymph nodes, liver or lungs, according to the Mayo Clinic.
Unfortunately, late-stage cancer diagnoses are not uncommon. A 2014 analysis from Cancer Research UK, for example, found that 46% of all cancers in that country were diagnosed at an advanced stage. A 2023 study published in the journal Lancet Oncology found disruptions in care amid the pandemic also led to an increase in late-stage diagnoses across nearly all cancer types, including prostate.
Slower-growing cancers can take years to develop and be detected, while more aggressive ones can become apparent more rapidly and also spread to other parts of the body quicker.
Biden, who is now 82, did not undergo prostate cancer screening during his last medical checkup while in office, in February 2024, according to records released at the time. Experts say this is likely due to that fact that these screenings are not routinely recommended for men 70 years or older.
"Doctors will stop screening for prostate cancer at 75 or so, because after that, the prostate cancers you typically pick up are very slow growing, and so the harms of all of the testing and treatment for something that may not kill you — you're talking about risk versus benefit. It may not be worth the risk," Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, explained on "CBS Mornings" Monday.
Instead, Biden's diagnosis came after he recently saw a doctor due to urinary symptoms. A small nodule was found in the prostate, which necessitated further evaluation, his office said last week.
"Urinary symptoms are quite common in older men and are usually due to benign conditions like having an enlarged prostate," Gounder said. In this case, however, the testing discovered cancer.
Gounder said the situation underscores the importance of tailoring medical decisions to the individual.
"He had new symptoms and is functionally active, which justified a closer look," she said.
There have been advancements in treating advanced prostate cancer, and Gounder said the treatment goal in a case like this would be to control the cancer, slowing its progression and preserving quality of life. Biden's type of cancer is hormone-sensitive, which means it should respond to a testosterone-blocking treatment, Gounder said, adding that this might be combined with other medications or chemotherapy, depending on the specific case.
Back in 2019, Biden was diagnosed with benign enlargement of the prostate, or BPH. That December, his campaign released his medical evaluation, which noted: "This patient has been treated for Benign Prostatic Hyperplasia (BPH). This was initially treated with medication and was then definitively treated with surgery. He has never had prostate cancer."
BPH is very common in older men, with around 80% of men over 70 having it, according to Yale Medicine.
How do doctors screen for prostate cancer?
Prostate cancer testing typically involves two methods: a prostate-specific antigen, or PSA, test and a digital rectal exam, or DRE. A PSA test is a type of blood test that can indicate a higher chance of prostate cancer but is not a definitive diagnosis. A DRE involves a doctor using a gloved finger to feel for any bumps on the prostate via the rectum.
The U.S. Preventive Services Task Force, an independent panel of national experts, say the decision on screening for prostate cancer among men aged 55 to 69 years should be an individual one — and it recommends against PSA screening for men 70 and older.
"Many men will experience potential harms of screening, including false-positive results that require additional testing and possible prostate biopsy; overdiagnosis and overtreatment; and treatment complications, such as incontinence and erectile dysfunction," the task force's recommendation summary notes. "Clinicians should not screen men who do not express a preference for screening."
Prostate cancer is common, second only to skin cancer as the most common cancer affecting males, according to the Cleveland Clinic. According to the Centers for Disease Control and Prevention, for every 100 males, 13 will develop prostate cancer at some point in their lives.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Meet the Philadelphia cancer patient being honored before Tuesday's Phillies' game
Meet the Philadelphia cancer patient being honored before Tuesday's Phillies' game

CBS News

time21 minutes ago

  • CBS News

Meet the Philadelphia cancer patient being honored before Tuesday's Phillies' game

A Philadelphia cancer patient will be honored at the Phillies' game on Tuesday night. The Fox Chase Cancer Center and the Phillies are joining forces for what they're calling Strike Out Cancer Night. The ceremonial first pitch will come from a young man who's part of a concerning trend. "As a lifelong Phillies fan, you think that you're gonna get to the major leagues by playing," Josh Breen said. "I think that this is a different way of going." As a young cancer patient, Breen will be throwing out the first pitch at the Phillies' Strike Out Cancer Night "Definitely a little bit of pressure," Breen said. In physical therapy now at Fox Chase, Breen knows all about pressure. A year ago, he was diagnosed with stage 3 melanoma, a deadly kind of skin cancer. It was right after his wedding. Breen was on his honeymoon in Italy and found a lump. "Very scary at the time," Breen said. "It's supposed to be the best part of your life. And then you kind of quickly get torn down." Breen was only 30 when he was diagnosed with stage 3 melanoma, which is part of a new trend of young people being diagnosed with different types of cancer. Josh Breen, who was diagnosed with stage 3 melanoma last year, will throw out the first pitch at Tuesday's Phillies' game as a part of Strike Out Cancer Night. CBS News Philadelphia "And many young patients, cancer is not on their radar as it should not be, but suddenly they're presenting with these small lesions that then can turn into bigger problems," Dr. Jeffrey Farma, of Fox Chase Cancer Center, said. Farma, the head of surgery at Fox Chase, said that before his surgery, Breen had immunotherapy, which is changing the face of cancer. "The survival and outcomes is really the best we've ever seen, so really, really exciting," Farma said. And the exciting cancer advancements now come with fertility options. "I was able to bank my sperm a week before I started immunotherapy treatment," Breen said. Breen and his wife, Sam, are expecting a baby boy on July 19. Fox Chase now has a program specifically for young cancer patients to help with everything from fertility to work, school and family issues. "From this moment that our younger patients are in the door, we're providing all of these resources in a combined program, which is amazing," Farma said. Breen said it's been a wild year of highs and lows. Now, it's just about getting his pitch over home plate. "Things are definitely trending in the right direction," Breen said. Breen will no doubt get plenty of applause Tuesday night before the game starts. He said he always uses sunscreen now, which is critical for guarding against skin cancer.

RFK Jr. removes all current members of CDC vaccine advisory committee
RFK Jr. removes all current members of CDC vaccine advisory committee

CNN

time36 minutes ago

  • CNN

RFK Jr. removes all current members of CDC vaccine advisory committee

US Health and Human Services Secretary Robert F. Kennedy Jr. on Monday dismissed an expert panel of vaccine advisers that has historically guided the federal government's vaccine recommendations, saying the group is 'plagued with conflicts of interest.' The entirety of the 17-member Advisory Committee for Immunization Practices, which advises the US Centers for Disease Control and Prevention on the vaccine schedule and required coverage of immunizations, will be retired and replaced with new members, Kennedy announced in a Wall Street Journal op-ed. The HHS secretary has authority to appoint and dismiss ACIP members, who typically serve four-year cycles. But removing the entire panel prematurely is unprecedented. Kennedy said that a number of the panel's members — traditionally pediatricians, epidemiologists, immunologists and other physicians — were 'last-minute appointees' of the Biden administration. 'Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028,' he wrote. ACIP members are not political appointees. However Kennedy, a longtime critic of federal vaccine policy and vaccine safety, argued that the current group is rife with conflicts of interest and has not been transparent in its vaccine recommendations. ACIP recently considered narrowing the recommendations for Covid-19 vaccinations among children. Kennedy had previously pledged to Sen. Bill Cassidy, a Republican from Louisiana and chairman of the Health, Education, Labor and Pensions Committee, that he would consult with the senator on filling key roles on vaccine advisory boards. A spokesperson for Cassidy did not immediately respond to a request for comment. The committee is scheduled to meet on June 25 to discuss vaccinations against Covid-19, RSV, influenza, HPV and meningococcal disease. HHS said the meeting will still take place, giving the agency roughly two weeks to fill its advisory panel. 'Appointing people this fast means they were not properly vetted, and there is no real time to check conflict of interests issues,' Dorit Reiss, a professor of law at UC Law San Francisco, told CNN. 'This will not restore trust in vaccines, and is not design to do so.'

RFK Jr. removes every member of CDC immunization advisory committee
RFK Jr. removes every member of CDC immunization advisory committee

CBS News

timean hour ago

  • CBS News

RFK Jr. removes every member of CDC immunization advisory committee

What to know about changes in CDC guidance for COVID-19 vaccine Washington — Health and Human Services Secretary Robert F. Kennedy Jr. on Monday said he is removing every member of a government panel that makes vaccine recommendations. Kennedy said he is "retiring" all 17 members of the Advisory Committee for Immunization Practices, asserting that it "has become little more than a rubber stamp for any vaccine." "A clean sweep is needed to re-establish public confidence in vaccine science," Kennedy, who is a vaccine skeptic, wrote in an opinion piece published by the Wall Street Journal. The members of the committee are independent medical and public health experts, who advise and vote on the Centers for Disease Control and Prevention's vaccine recommendations. The CDC sets immunization schedules for both adults and children based on recommendations from ACIP. Experts and health authorities closely watch the committee's decisions, since their recommendations are tied to a number of federal policies, including requirements for insurance coverage and liability protections. Career CDC officials usually select experts to sit on the committee out of the applications it receives, forwarding picks to the secretary to be signed off on. Kennedy said the Trump administration would not have been able to appoint a majority of new members until 2028 because some of the current members were last-minute appointees of the Biden administration. "The prior administration made a concerted effort to lock in public health ideology and limit the incoming administration's ability to take the proper actions to restore public trust in vaccines," Kennedy said. It is unclear who is being considered to replace the committee's members or how they are being selected. A spokesperson for the department did not comment when asked. The move comes a week after a committee leader, Dr. Lakshmi Panagiotakopoulos, resigned from her role following an order from Kennedy to change the CDC's guidance on COVID-19 vaccine recommendations. Outside groups voiced disappointment over the move, which bypassed the longstanding advisory committee process and usurped an already-ongoing work group within the panel that had already been weighing how to narrow COVID-19 vaccine recommendations. Kennedy's ouster of the committee's members comes ahead of a meeting of the panel scheduled to start on June 25. The panel was expected to vote on new recommendations for COVID-19 and other vaccines. Updates voted on from the last committee meeting in April to RSV and meningococcal vaccine recommendations were never adopted by Kennedy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store